Operating Income for DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current operating income (TTM) is $911.80M USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DXCM
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$911.80M
YoY change
+52.0%
5Y CAGR
+24.9%
Peak year (2025)
$911.80M
Cumulative operating income
$2.39B
Operating Income history chart for DexCom (DXCM) from 2000 to 2025
Operating Income history table for DexCom (DXCM) from 2000 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $911.80M | +52.0% | ||
| 2024 | $600.00M | +0.4% | ||
| 2023 | $597.70M | +52.8% | ||
| 2022 | $391.20M | +47.2% | ||
| 2021 | $265.80M | -11.3% | ||
| 2020 | $299.50M | +110.5% | ||
| 2019 | $142.30M | -176.4% | ||
| 2018 | -$186.30M | +338.4% | ||
| 2017 | -$42.50M | -33.5% | ||
| 2016 | -$63.90M | +11.9% | ||
| 2015 | -$57.10M | +165.6% | ||
| 2014 | -$21.50M | -25.6% | ||
| 2013 | -$28.90M | -48.1% | ||
| 2012 | -$55.70M | +24.2% | ||
| 2011 | -$44.84M | -1.0% | ||
| 2010 | -$45.29M | -1.2% | ||
| 2009 | -$45.83M | -13.2% | ||
| 2008 | -$52.83M | +13.2% | ||
| 2007 | -$46.68M | -5.4% | ||
| 2006 | -$49.32M | +52.1% | ||
| 2005 | -$32.43M | +130.5% | ||
| 2004 | -$14.07M | +38.1% | ||
| 2003 | -$10.18M | +61.4% | ||
| 2002 | -$6.31M | -6.1% | ||
| 2001 | -$6.72M | +67.5% | ||
| 2000 | -$4.01M | — |
Operating Income values are taken from DexCom's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
DexCom (DXCM) most recent annual operating income stands at $911.80M (2025) – surged 52.0% year-over-year.
DexCom operating income has grown for 4 consecutive years, with a +24.9% compound annual growth rate over 2020–2025 (5 years).
The dataset's maximum operating income sits at $911.80M (2025); the minimum reading of -$186.30M dates to 2018.
Within Healthcare, DexCom (DXCM) ranks 9th among 8 peers we track. The peer median for operating income is $22.84B.
DexCom Operating Income by Year
DexCom Operating Income 2025: $911.80M
DexCom operating income in 2025 was $911.80M, surged 52.0% from 2024. This figure represents the highest annual value in the available history.
DexCom Operating Income 2024: $600.00M
DexCom operating income in 2024 was $600.00M, edged up 0.4% from 2023.
DexCom Operating Income 2023: $597.70M
DexCom operating income in 2023 was $597.70M, surged 52.8% from 2022.
DexCom Operating Income 2022: $391.20M
DexCom operating income in 2022 was $391.20M, surged 47.2% from 2021.
DexCom Operating Income 2021: $265.80M
DexCom operating income in 2021 was $265.80M.
See more financial history for DexCom (DXCM).
Sector peers — Operating Income
Companies in the same sector as DexCom, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is DexCom's operating income?
- Latest reported operating income for DexCom (DXCM) is $911.80M (period ending December 31, 2025).
How has DexCom operating income changed year-over-year?
- DexCom (DXCM) operating income changed +52.0% year-over-year on the latest annual filing.
What is the long-term growth rate of DexCom operating income?
- DexCom (DXCM) operating income compound annual growth rate is +24.9% over the most recent 5 years available.
When did DexCom operating income hit its highest annual value?
- DexCom operating income reached its highest annual value of $911.80M in 2025.
What was DexCom operating income in 2024?
- DexCom (DXCM) operating income in 2024 was $600.00M.
What was DexCom operating income in 2025?
- DexCom (DXCM) operating income in 2025 was $911.80M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DXCM Overview
Company profile, financial tools, and key metrics
DXCM Revenue Counter
Earns $147.83 every second. See per minute, hour, and day.
DXCM Earnings Counter
Earns $26.52 per second net profit. See per minute, hour, and day.
DXCM Economic Scale
Exceeds Suriname's GDP. Compare with world economies.
DXCM What If Invested
What if you had invested $1,000? See historical returns from any date.
DXCM How It Makes Money
Discover visual breakdown of $4.66B in revenue — where it comes from and where it goes.
DXCM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DXCM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DXCM Daily Price Character
Explosive · 49.4% historical win rate (green days). Streaks & record days.
DXCM Buybacks
1.95% TTM buyback yield. Shareholder yield & SBC comparison.
DXCM Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.